|Seed, 6/10 |
Eqvitec Partners Oy
MediSapiens is the worldâ€™s first software company for personalized cancer medicine in oncology clinics and new drug development. Companyâ€™s bioinformatics science and peer-reviewed data is based on the research since 2005 by VTT, Technical Research Centre of Finland and its collaborators.
Company’s online genomics data enables scientists to understand the role of human genes in health and disease â€“ helping oncologists in choosing optimal treatments and biopharmaceutical companies in developing next generation personalized medicines.